Funder
Fundação para a Ciência e a Tecnologia
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference77 articles.
1. Aghazadeh Y, Papadopoulos V (2016) The role of the 14-3-3 protein family in health, disease, and drug development. Drug Discov Today 21(2):278–287
2. Bernitsas E, Wei W, Mikol DD (2006) Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane. Ann Neurol 59(1):206–209
3. Boland MP, Fitzgerald KA, O'Neill LAJ (2000) Topoisomerase II Is required for mitoxantrone to signal nuclear factor κB activation in HL60 Cells. J Biol Chem 275(33):25231–25238
4. Brown DA, Perry JB, Allen ME et al (2017) Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol 14(4):238–250
5. Canal P, Attal M, Chatelut E et al (1993) Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Res 53(20):4850–4854
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献